免疫抑制机制和治疗干预措施塑造了质母细胞瘤免疫
Pilar M Moreno-Sanchez1,2, Mahsa Rezaeipour1,2, Else Marit Inderberg3
1NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
Nature cancer
|January 8, 2026
概括
侵略性质母细胞瘤 (GBM) 瘤是塑性的,允许免疫细胞创建抑制性瘤微环境 (TME). 了解TME动态是克服治疗耐药性和改善患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 质母细胞瘤 (GBM) 具有显著的可塑性,这种特性有助于瘤细胞和瘤微环境 (TME) 适应各种条件并抵抗治疗.
- 在GBM中,TME在瘤进展和治疗逃避中起着至关重要的作用.
- 在TME内的免疫细胞是促进GBM生长的免疫抑制环境的关键贡献者.
研究的目的:
- 讨论先天性和适应性免疫细胞在 GBM 中建立免疫抑制性 TME 的协作作用.
- 突出治疗干预如何改变TME并导致治疗耐药性.
- 引入新的概念,以提高针对GBM的治疗疗效.
主要方法:
- 本研究是讨论和概念概述,不基于实验数据.
- 它综合了GBM TME内的免疫细胞相互作用的当前知识.
- 它回顾了治疗策略对TME的影响.
主要成果:
- 天生和适应性免疫参与者在空间和时间上合作,产生一种免疫抑制的TME.
- 这种免疫抑制的TME促进了GBM的生长和对常规治疗和免疫疗法的抵抗.
- 治疗干预可以重塑TME,但往往会导致抵抗.
结论:
- 需要有针对性的方法来克服GBM中TME介导的抗性.
- 局部TME启动对于启动有效的抗瘤免疫反应至关重要.
- TME重新连接策略对于在GBM患者中实现持久的临床反应至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Cell-mediated Immune Responses
83.4K
Overview
83.4K


